Quantcast

Latest Artemisinin Stories

2008-07-18 18:00:11

WASHINGTON - Plans for a large-scale trial of a potential AIDS vaccine are being dropped in favor of a smaller, more focused study, the National Institutes of Health said Thursday. The trial of the vaccine, developed by the Vaccine Research Center at the National Institute of Allergy and Infectious Disease, had been planned to include 2,400 men in the United States in a study called PAVE 100. However, the agency said that it decided that the vaccine did not warrant a trial of this scope....

f83148159fd866cd3cb1b4428b0224bd1
2008-02-12 15:55:00

A one of its kind collaborative study between scientists, health workers and police has led to the arrest of alleged traders of fake anti-malarial drugs in China. The investigation highlights the growing threat posed by fake pharmaceuticals and the difficulties of tracking down those responsible for their manufacture. The investigation, known as "Operation Jupiter," included INTERPOL, the World Health Organization's Western Pacific Regional Office, and the Wellcome Trust-University of...

2006-07-02 13:21:18

WASHINGTON (Reuters) - An allergy drug pulled off the market in 1999 could work to treat malaria, U.S. researchers reported on Sunday. The drug is called astemizol and marketed under the brand name Hismanal by Janssen Pharmaceutica, a unit of Johnson & Johnson, and can kill the Plasmodium falciparum parasite that causes malaria. Researchers from the Johns Hopkins University Schools of Medicine and Public Health tested astemizol in test tubes and in mice. Moderate doses reduced...

2006-07-02 12:00:00

WASHINGTON (Reuters) - An allergy drug pulled off the market in 1999 could work to treat malaria, U.S. researchers reported on Sunday. The drug is called astemizol and marketed under the brand name Hismanal by Janssen Pharmaceutica, a unit of Johnson & Johnson, and can kill the Plasmodium falciparum parasite that causes malaria. Researchers from the Johns Hopkins University Schools of Medicine and Public Health tested astemizol in test tubes and in mice. Moderate doses reduced the numbers...

2006-05-23 08:05:00

By Thomas Atkins ZURICH (Reuters) - Drugmaker Novartis aims to create a one-dose cure for the most dangerous form of malaria in a public partnership to address one of the world's top killer diseases, the Swiss company said on Tuesday. Novartis is launching the project at its Institute for Tropical Diseases (NITD) in Singapore to design a one-dose cure for Plasmodium falciparum, the most dangerous form of malaria, and a treatment for Plasmodium vivax, the most frequent and widely distributed...

2006-05-11 11:44:59

GENEVA (Reuters) - Thirteen drug companies have agreed to phase out single-drug artemisinin medicines for treating malaria, blamed for speeding resistance in parasites, the World Health Organization (WHO) said on Thursday. The United Nations agency appealed in January to all 40 producers to stop marketing artemisinin monotherapy pills and redirect production to artemisinin combination therapies (ACTs). "This group (of 13) includes the main producers of high-quality artemisinin...

2006-04-24 14:30:00

By Laura MacInnis GENEVA (Reuters) - Most of the world's millions of malaria sufferers are not getting life-saving drugs nearly five years after the World Health Organization urged their widespread use, despite a huge boost in aid, health experts said on Monday. The U.N. health agency has since 2001 recommended countries switch to artemisinin-based combination drugs -- known as ACTs -- to treat malaria because the deadly mosquito-borne infection had become resistant to conventional medicines...

2006-04-12 14:50:00

NEW YORK (Reuters Health) - US researchers have created a modified form of the yeast Saccharomyces cerevisiae that is capable of producing large amounts of artemisinic acid, which is needed to make the anti-malaria drug artemisinin. Malaria, caused by the one-celled parasite carried by mosquitoes called plasmodium, kills at least one million people every year and makes 300 million people seriously ill. Ninety percent of malaria deaths occur in Africa, south of the Sahara, mostly among young...

2006-03-08 08:30:00

By Maggie Fox, Health and Science Correspondent WASHINGTON -- Companies that develop drugs to treat diseases of poor countries such as malaria should be rewarded with vouchers that might speed up government review of far more lucrative drugs, researchers proposed on Tuesday. Another set of researchers suggested that rich countries subsidize the use of the most effective drugs to fight malaria in poorer nations. Both reports, published in the journal Health Affairs, are aimed at finding ways...

2006-01-20 00:20:00

WASHINGTON -- The World Health Organization asked pharmaceutical companies on Thursday to end the marketing and sale of "single-drug" artemisinin malaria medicines, in order to prevent malaria parasites from developing resistance to the drug. The use of single-drug artemisinin treatment, or "monotherapy," hastens development of resistance by weakening but not killing the parasite, WHO said in new malaria treatment guidelines. "We request pharmaceutical companies to immediately stop marketing...


Word of the Day
mundungus
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.